4/A: GeneDx Insider Corrects Share Ownership Filing
Beneficial Ownership Amendment
Keith A. Meister and Corvex Management LP amended a Form 4 to correct the reported beneficial ownership of GeneDx Holdings Corp. Class A Common Stock.
Summary
- The filing is an amendment (Form 4/A) to a previously filed Form 4 dated November 17, 2023, for GeneDx Holdings Corp. (WGS).
- The amendment corrects an administrative error in the number of Class A Common Stock shares beneficially owned by Keith A. Meister and Corvex Management LP.
- The corrected total beneficial ownership for Mr. Meister is 2,806,925 shares of Class A Common Stock.
- This total includes 2,473,781 shares held by investment funds advised by Corvex Management LP and 333,144 shares held by CMLS Holdings LLC.
- Mr. Meister is a Director and 10% Owner of GeneDx Holdings Corp. and controls the general partner of Corvex Management LP, and shares voting and investment discretion for CMLS Holdings LLC.
- All reported numbers reflect the Issuer's 1-for-33 reverse stock split that became effective on May 4, 2023.
- Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Sentiment
Score: 5
Explanation: The filing is an administrative correction to previously reported beneficial ownership, which is neutral in terms of company performance but positive for data accuracy and transparency.
Positives
- The amendment improves the accuracy of public records regarding insider beneficial ownership, enhancing transparency for investors.
- The correction clarifies the exact holdings of a significant insider and 10% owner, Keith A. Meister, and associated entities.
Negatives
- The need for an amendment indicates an administrative error in the original filing, which suggests a minor oversight in internal reporting processes.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding the company's future performance or operations.
Management Comments
- Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- The Form 4 filed on November 17, 2023, is being amended hereby to correct the number of shares of the Issuer's Class A Common Stock reported in Column 5 of Table I and the related footnotes 1 and 2, which numbers were misstated in the original report due to administrative error.
Industry Context
This filing is an administrative correction of insider ownership, which is a standard regulatory disclosure. It does not provide information directly related to broader industry trends or competitive positioning within the genomics or diagnostics sector, but rather ensures accurate reporting of significant shareholder stakes.
Stakeholder Impact
- Shareholders: Provides accurate and transparent information regarding the beneficial ownership of a significant insider and 10% owner, Keith A. Meister, and associated entities, which is crucial for informed investment decisions.
Next Steps
- Any subsequent Forms 4 filed by the Reporting Persons through the date of this amendment should be read to incorporate this correction in the context of any transactions reported therein.
Key Dates
| Date | Description |
|---|---|
| 05/04/2023 | Effective date of GeneDx Holdings Corp.'s 1-for-33 reverse stock split. |
| 11/15/2023 | Date of earliest transaction reported in the original Form 4. |
| 11/17/2023 | Date of original Form 4 filing that is being amended. |
| 10/06/2025 | Signature date on the amended filing by Keith A. Meister. |
Keywords
GeneDx Holdings, WGS, Keith Meister, Corvex Management, beneficial ownership, SEC filing, Form 4/A, insider ownership, stock split
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.